Updated Jul 16, 2026
COLLIS STEVEN H has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $1.14M. Lifetime open-market sales: $52.72M.
Steven H. Collis is the Executive Chairman and a Director at Cencora, Inc., a leading pharmaceutical wholesaler in the U.S. He has played a significant role in the pharmaceutical distribution industry and has previously held executive positions at Elevance Health, Inc.
| Role | Director |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-28 | BLCO | Bausch & Lomb Corp | A — Grant or award | 15.8K | $15.78 | $250K |
| 2026-05-15 | ELV | Elevance Health, Inc. | A — Grant or award | 563 | $0.00 | |
| 2026-05-01 | BLCO | Bausch & Lomb Corp | A — Grant or award | 1.4K | $15.90 | $22K |
| 2026-03-06 | ELV | Elevance Health, Inc. | P — Open-market purchase | 3.0K | $289.84 | $870K |
| 2026-02-24 | BLCO | Bausch & Lomb Corp | A — Grant or award | 4.5K | $0.00 | |
| 2026-02-24 | BLCO | Bausch & Lomb Corp | P — Open-market purchase | 15.0K | $17.81 | $267K |
| 2026-02-23 | BLCO | Bausch & Lomb Corp | A — Grant or award | 5.3K | $0.00 | |
| 2025-09-16 | COR | Cencora, Inc. | S — Open-market sale | 31.4K | $289.86 | $9.09M |
| 2025-09-16 | COR | Cencora, Inc. | M — Option exercise | 29.4K | $86.09 | $2.53M |
| 2025-08-19 | COR | Cencora, Inc. | S — Open-market sale | 14.6K | $289.98 | $4.23M |
| 2025-08-19 | COR | Cencora, Inc. | M — Option exercise | 12.6K | $86.09 | $1.08M |
| 2025-08-01 | ELV | Elevance Health, Inc. | A — Grant or award | 639 | $0.00 | |
| 2025-07-22 | COR | Cencora, Inc. | S — Open-market sale | 14.6K | $292.67 | $4.27M |
| 2025-07-22 | COR | Cencora, Inc. | M — Option exercise | 12.6K | $86.09 | $1.08M |
| 2025-06-24 | COR | Cencora, Inc. | S — Open-market sale | 14.6K | $292.62 | $4.27M |
| 2025-06-24 | COR | Cencora, Inc. | M — Option exercise | 12.6K | $86.09 | $1.08M |
| 2025-05-20 | COR | Cencora, Inc. | S — Open-market sale | 14.6K | $293.84 | $4.28M |
| 2025-05-20 | COR | Cencora, Inc. | M — Option exercise | 12.6K | $86.09 | $1.08M |
| 2025-04-22 | COR | Cencora, Inc. | S — Open-market sale | 14.6K | $281.81 | $4.11M |
| 2025-04-22 | COR | Cencora, Inc. | M — Option exercise | 12.6K | $86.09 | $1.08M |
Steven H. Collis is the Executive Chairman and a Director at Cencora, Inc., a leading pharmaceutical wholesaler in the U.S. He has played a significant role in the pharmaceutical distribution industry and has previously held executive positions at Elevance Health, Inc.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases ($1.14M) and 9 open-market sales ($52.72M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live COLLIS STEVEN H profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.